European Heart Journal · 2006 · 157 citations · 20 references
MedicineCardiologyClinical BiochemistryClinical CardiologyPulmonologyCardiac BiomarkersCardiac Risk AssessmentPulmonary EmbolismBiomarker-based Early DetectionBiomarker-based Prognostic ModelsCardiac Biomarker EvaluationFatty Acid BindingHeart-type Fatty Acid-binding ProteinOverall MortalityPulmonary Embolism Risk StratificationTroponin Elevation
AIMS: We investigated the value of a novel early biomarker, heart-type fatty acid-binding protein (H-FABP), in risk stratification of patients with acute pulmonary embolism (PE). METHODS AND RESULTS: We prospectively included 107 consecutive patients with confirmed PE. The endpoints were (i) PE-related death or major complications and (ii) overall 30-day mortality. Overall, 29 patients (27%) had abnormal (>6 ng/mL) H-FABP levels at presentation. Of those, 12 (41%) had a complicated course, whereas all patients with normal baseline H-FABP had a favourable 30-day outcome (OR, 71.45; P<0.0001). At multivariable analysis, H-FABP (P<0.0001), but not cardiac troponin T (P=0.13) or N-terminal pro-brain natriuretic peptide (P=0.36), predicted an adverse outcome. Evaluation of a strategy combining biomarker testing with echocardiography revealed that patients with a negative H-FABP test had an excellent prognosis regardless of echocardiographic findings. In contrast, patients with a positive H-FABP test had a complication rate of 23.1% even in the presence of a normal echocardiogram, and this rose to 57.1% if echocardiography also demonstrated right ventricular dysfunction (OR vs. a negative H-FABP test, 5.6 and 81.4, respectively). CONCLUSION: H-FABP is a promising early indicator of right ventricular injury and dysfunction in acute PE. It may help optimize risk stratification algorithms and treatment strategies.
20
Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
Philip S. Wells, David R. Anderson, Marc Rodger et al. · New England Journal of Medicine · 2003 · 1.5K citations · Full text
Biochemical detection of left-ventricular systolic dysfunction
T. McDonagh, SD Robb, J.J. Morton et al. · The Lancet · 1998 · 973 citations
Medicine, Cardiology, Physiology +13
R.W. van der Meer, Peter M. T. Pattynama, Marco J. L. van Strijen et al. · Radiology · 2005 · 501 citations
Medicine, Cardiology, Radiology +17